Stay updated on TAK-861 Study in Narcolepsy Type 2 Clinical Trial
Sign up to get notified when there's something new on the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page.

Latest updates to the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1; no changes to core content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedThe page update removes a generic government funding operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedResults have been posted for NCT05687916 (Results First Posted 2025-01-09), and the study record now shows updated enrollment and completion data along with the outcomes reporting dates.SummaryDifference0.3%

- Check65 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check72 days agoChange DetectedRemoved MedlinePlus Drug Safety topic and related MeSH terms (Substandard Drugs, Pharmaceutical Preparations, Counterfeit Drugs); overall topic scope is narrowed. No new content added.SummaryDifference0.5%

Stay in the know with updates to TAK-861 Study in Narcolepsy Type 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page.